Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Balance Sheets

v3.19.2
Condensed Consolidated Interim Balance Sheets - USD ($)
Jun. 30, 2019
Mar. 31, 2019
Current    
Cash and cash equivalents $ 530,031 $ 446,779
Accounts receivable, net of allowance for doubtful accounts of $Nil (March 31, 2019 - $Nil) 1,027,012 1,523,193
Prepaid expenses and other receivables (Note 5) 1,194,727 1,355,032
Inventories (Note 6) 582,058 405,682
Due from related parties (Note 9(a)) 19,068 18,585
Total Current Assets 3,352,896 3,749,271
Equipment (Note 7) 211,360 192,528
Technology and other assets (Note 4) 4,358,408 4,427,722
Goodwill 22,308,275 22,308,275
Total Assets 30,230,939 30,677,796
Current    
Accounts Payable (Notes 9(b)) 1,055,017 1,148,852
Accrued liabilities (Note 8 and 9(b)) 1,620,632 1,653,233
Convertible Loans (Note 8(a)) 954,450 0
Deferred revenue - Contract Liabilities 525,794 467,778
Total Current Liabilities 4,155,893 3,269,863
Term loan (Note 8(b)) 500,000 0
Total Liabilities 4,655,893 3,269,863
Shareholders' Equity    
Preferred Stock, par value $0.001; Authorized 10,000,000 Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2019 - 1)
Common Shares, par value $0.001; Authorized - 500,000,000 (March 31, 2019 - 500,000,000); Issued and outstanding 3,702,398 and 156,239 Exchangeable Shares (March 31, 2019 -3,661,838 and 196,799 Exchangeable Shares) 3,858 3,858
Additional paid in capital 74,007,056 73,719,299
Deficit (48,478,017) (46,357,373)
Accumulated other comprehensive income 42,149 42,149
Total Shareholders' Equity 25,575,046 27,407,933
Total Liabilities and Shareholders' Equity $ 30,230,939 $ 30,677,796